Healthcare Sector Analytics

Market size, company revenue, drug approvals, clinical trials, regulation, hospitals, doctors, drug spending, labs and devices

Generic drugFirst approved 2012

Amphetamine Sulfate

Medicare prescription drug cost, prescriptions and prescribers, 2024

$128K

Medicare cost, 2024

Medicare drug plans spent $128,109 on Amphetamine Sulfate in 2024, for 991 prescriptions and refills filled by 213 patients. Spending fell 30% from 2023 to 2024. California accounts for the most spending ($21,424, 17% of the total).

Medicare cost, 2024

$128K

-30.2% from 2023

Prescriptions

991

$129.27 per claim

Patients

213

241 prescribers

Total spending, 2024

$128K

$601.38 per patient

Questions and answers

How much does Medicare spend on Amphetamine Sulfate?

Medicare prescription drug plans paid $128K for Amphetamine Sulfate in 2024, for 991 prescriptions and refills to 213 patients (down 30.2% from 2023). The average cost per claim was $129.27.

Which state spends the most on Amphetamine Sulfate?

California had the highest Medicare cost for Amphetamine Sulfate in 2024: $21K for 104 claims, followed by Virginia ($12K).

Who prescribes Amphetamine Sulfate the most?

Allan B Phillips, psychiatry & neurology in Sherman Oaks, CA, had the highest Medicare cost for Amphetamine Sulfate in 2024: 13 claims costing $8,072.

Spending over the years

Medicare spending by year

All plans and makers

Prescriber data: cost by year

Medicare spending on Amphetamine Sulfate was $128K in 2024, after a high of $185K in 2020.

By state

Where the prescribers practice, 2024

Medicare cost by state

States with the highest cost

Top prescribers of Amphetamine Sulfate, 2024

By Medicare drug cost

PrescriberTypeClaimsPatientsCost
Allan B Phillips Sherman Oaks, CAPsychiatry & Neurology13Under 11$8,072
Rabia Jafri Newport News, VAPsychiatry11Under 11$4,493
Emelia Perez Simi Valley, CAFamily Practice11Under 11$3,938
Emil Soorani Santa Monica, CASpecialist11Under 11$3,756
Darla M Burnett Baton Rouge, LAPsychologist, Clinical27Under 11$3,535
Vivek Agnihotri Creve Coeur, MONeuropsychiatry12Under 11$2,879
Christopher C Laganke Cullman, ALNeurology27Under 11$2,797
Nalini O Morris Canton, OHPsychiatry12Under 11$2,618
Wade A Hachinsky Leawood, KSPsychiatry13Under 11$2,509
James B Payton Asheville, NCNeuropsychiatry23Under 11$2,320
Joe B Speer Tulsa, OKPsychiatry & Neurology11Under 11$2,185
Kelly Shephard Henrico, VANurse Practitioner11Under 11$1,508
Latoya Mullen Virginia Beach, VANurse Practitioner11Under 11$1,447
Osvaldo Gaytan Jr. El Paso, TXPsychiatry13Under 11$1,427
Brian H Johns Minneapolis, MNPsychiatry11Under 11$1,128
Carol D Crouch-Ross Livonia, MIPsychiatry12Under 11$1,094
Neil Mushlin Lansdale, PAPulmonary Disease11Under 11$1,071
Jill Powell Knoxville, TNNurse Practitioner16Under 11$1,051
Joseph P McNally Algonquin, ILPsychiatry12Under 11$1,013
Kenneth S Davis Louisville, KYPsychiatry & Neurology15Under 11$962
John Conciatori Whitestone, NYRegistered Nurse12Under 11$880
David L Snow Maryville, TNPsychiatry11Under 11$776
Lora A Crowley Doylestown, PANurse Practitioner12Under 11$473
Maureen Kolomeir Albuquerque, NMNurse Practitioner12Under 11$419
Jennifer K Frascone Greenwich, CTPhysician Assistant12Under 11$418

Prescriber data by year

YearPrescribersClaimsPatientsCost
2022200729179$170K
2023234844204$184K
2024241991213$128K

Makers, 2024

Spending by manufacturer as listed in the spending data

ManufacturerClaimsSpending
Amneal PharmaceAMRX logoAMRX418$48K
Granules PharmaGRANULES.NS logoGRANULES.NS243$37K
Lannett Co. Inc183$27K
Dr.Reddy'S LabRDY logoRDY123$14K
Wilshire Pharma23$1,974

Medicaid spending by quarter

Amount reimbursed by state Medicaid programs, all states

Amount reimbursed

Codes

National drug codes (packages)
30
RxNorm concept IDs
1600695, 884655
Application numbers
ANDA200166, ANDA211139, ANDA211639, ANDA211861, ANDA212619

More drugs: Medicare drug spending and the Prescriptions view.

Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.

LinkedInLinkedInXXYouTubeYouTube